Market closedNon-fractional

Tandem Diabetes Care/TNDM

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Tandem Diabetes Care

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Ticker

TNDM

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

San Diego, United States

Employees

2,400

TNDM Metrics

BasicAdvanced
$2.5B
Market cap
-
P/E ratio
-$2.17
EPS
1.27
Beta
-
Dividend rate
$2.5B
1.27
3.81
2.906
189.345
196.47
-12.49%
-9.70%
-48.62%
3.31
10.33
10.33
-38.24
-3.11%
-31.37%
12.42%
76.08%

What the Analysts think about TNDM

Analyst Ratings

Majority rating from 18 analysts.
Buy

TNDM Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-22.28% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$192M
-2.59%
Net income
-$43M
42.33%
Profit margin
-22.28%
46.10%

TNDM Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 16.85%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.30
-$0.38
-$0.27
-$0.63
-
Expected
-$0.53
-$0.34
-$0.25
-$0.76
-$0.54
Surprise
-43.60%
13.02%
6.01%
-16.85%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Tandem Diabetes Care stock?

Tandem Diabetes Care (TNDM) has a market cap of $2.5B as of July 04, 2024.

What is the P/E ratio for Tandem Diabetes Care stock?

The price to earnings (P/E) ratio for Tandem Diabetes Care (TNDM) stock is 0 as of July 04, 2024.

Does Tandem Diabetes Care stock pay dividends?

No, Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Tandem Diabetes Care dividend payment date?

Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders.

What is the beta indicator for Tandem Diabetes Care?

Tandem Diabetes Care (TNDM) has a beta rating of 1.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Tandem Diabetes Care stock

Buy or sell Tandem Diabetes Care stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing